Dr Izanne Roos
Senior Research Fellow in Multiple Sclerosis
Department of Medicine
152 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder
DOI: 10.1212/WNL.00000000002147072026
Journal article
Performance of the 2024 McDonald diagnostic criteria for multiple sclerosis
DOI: 10.1177/135245852614218162026
Journal article
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis
DOI: 10.1093/brain/awaf2862026
Journal article
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
DOI: 10.1007/s00415-026-13632-42026
Research grants (ARC, NHMRC, MRFF)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2025
Research grants (ARC, NHMRC, MRFF)
Evidence Based Use of High-Efficacy Therapies in Multiple Sclerosis
2022
Research Grant
Personalised Therapy to Prevent Disability in Aggressive Multiple Sclerosis
RECENT SCHOLARLY WORKS
2026
Journal article
Managing reactivation of multiple sclerosis during treatment with natalizumab
DOI: 10.1177/135245852513986822026
Journal article
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry
DOI: 10.1177/175628642614300842026
Journal article
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study
DOI: 10.1007/s40263-026-01287-82026
Journal article
Neurological implications of chimeric antigen receptor-T cell therapy
DOI: 10.1136/bmjno-2025-0014912025
Conference Proceedings
247 Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation
DOI: 10.1136/jnnp-2025-abn.2472025
Conference Proceedings
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years
DOI: 10.1136/jnnp-2025-336343
RECENT PROJECTS
2026
Research grants (other domestic)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2026
Research grants (other domestic)
Do Anti-Cd20 Therapies Benefit Non-Active Progressive MS? A Causal Inference Analysis Using Observational Data